Standard Biotools (LAB) Revenue Growth (3y) (2013 - 2026)
Powered by 
Analysis
Standard Biotools (LAB) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | 3.92% |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | 1.95% |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | 3.95% |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | -0.48% |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | 0.96% |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 2.15% |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | -1.50% |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | 8.65% |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | 0.95% |
| 10 | Standard Biotools | 285.26 Mn | -191.45 Mn | 10.54 Mn | -10.10% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.10% |
| Mar 31, 2026 | -5.58% |
| Dec 31, 2025 | -4.15% |
| Sep 30, 2025 | -8.65% |
| Jun 30, 2025 | 5.04% |
| Mar 31, 2025 | -8.62% |
| Sep 30, 2024 | -37.92% |
| Jun 30, 2024 | -29.36% |
| Mar 31, 2024 | 11.57% |
| Dec 31, 2023 | -14.19% |
| Sep 30, 2023 | -13.99% |
| Jun 30, 2023 | 2.02% |
| Mar 31, 2023 | -3.11% |
| Dec 31, 2022 | -5.91% |
| Sep 30, 2022 | -1.08% |
| Jun 30, 2022 | -12.67% |
| Mar 31, 2022 | -4.16% |
| Sep 30, 2021 | 47.17% |
| Jun 30, 2021 | 34.16% |
| Mar 31, 2021 | 9.11% |